Adoption of Commission Delegated Regulation (EU) 2025/788 amending Delegated Regulation (EU) 2023/2197 as regards the date of application and new revision of MDCG 2024-14

    Adoption of Commission Delegated Regulation (EU) 2025/788 amending Delegated Regulation (EU) 2023/2197 as regards the date of application and new revision of MDCG 2024-14

    Regulatory Affairs Medical Devices

    Tuesday, 30 September 2025

    person-image

    Kirsten Van Garsse, Authorized Representative Director & Regulatory Affairs Manager IVD

    share-iconshare-icon-mob Share

    X (Twitter) icon\ \ X (Twitter) LinkedIn icon\ \ LinkedIn WhatsApp icon\ \ WhatsApp Copy link icon\ \ Copy link Mail icon\ \ Mail

    On 28 July 2025the Commission Delegated Regulation (EU) 2025/788 amending Delegated Regulation (EU) 2023/2197 as regards the date of application was adopted.

    Play

    Adoption of Commission Delegated Regulation (EU) 2025/788 | QbD Group

    AI-generated audio

    1:42

    The amendment defers the application of the rules on the assignment of Unique Device Identifiers (UDI) for contact lenses as highly individualised devices, introduced through the Master UDI-DI solution, to 9 November 2026. The change responds to the need for operators to have sufficient time to implement the technical and organisational requirements, following the publication of the MDCG 2024-14 guidance on the implementation of the Master UDI-DI solution for contact lenses. By postponing the application date, the amendment ensures greater legal certainty, allows adequate planning and resource allocation, and supports a smoother transition to the new UDI framework.

    On 26 August 2025, the Medical Device Coordination Group (MDCG) released a new revision of the MDCG 2024-14 which includes guidance on the implementation of the Master UDI-DI solution for contact lenses. The revision of the MDCG includes references to the Delegated Regulation 2025/788 and the new date of application of the Master UDI-DI for contact lenses (9 November 2026).

    What does this mean for you?

    Manufacturers now have extended time to implement the Master UDI-DI for contact lenses, allowing for better resource allocation, planning, and system adaptation. Ensure your UDI and EUDAMED processes are aligned with the updated timelines.

    CTA RA update MD

    Discover more expert content

    Previous

    Regulatory Affairs

    15 Nov 2024

    MDCG 2023-3 Rev 1 released

    On November 11th, 2024, the Medical Device Coordination Group (MDCG) released its first revision...

    Read more

    Regulatory Affairs

    5 Nov 2024

    New Q&A on the obligation to inform in case of interruption or discontinuation of supply

    On October 30th, 2024, the Medical Device Coordination Group (MDCG) released a Q&A on the...

    Read more

    Regulatory Affairs

    5 May 2025

    New UK Clinical Trials Regulations: Key Updates and What They Mean

    These changes aim to enhance patient safety, expedite approvals, foster innovation, and make it...

    Read more

    Regulatory Affairs

    11 Jul 2024

    Publication of Amendments to Regulation (EU) 2024/1860

    Regulation (EU) 2024/1860 as regards a gradual roll-out of Eudamed, the obligation to inform in...

    Read more

    Regulatory Affairs

    23 Feb 2024

    EU Council Endorses Proposal to Amend IVDR and MDR Regulations

    The Council of the European Union officially endorsed without any changes the proposal to amend...

    Read more

    Regulatory Affairs

    15 Nov 2024

    MDCG 2023-3 Rev 1 released

    On November 11th, 2024, the Medical Device Coordination Group (MDCG) released its first revision...

    Read more

    Regulatory Affairs

    5 Nov 2024

    New Q&A on the obligation to inform in case of interruption or discontinuation of supply

    On October 30th, 2024, the Medical Device Coordination Group (MDCG) released a Q&A on the...

    Read more

    Regulatory Affairs

    5 May 2025

    New UK Clinical Trials Regulations: Key Updates and What They Mean

    These changes aim to enhance patient safety, expedite approvals, foster innovation, and make it...

    Read more

    Regulatory Affairs

    11 Jul 2024

    Publication of Amendments to Regulation (EU) 2024/1860

    Regulation (EU) 2024/1860 as regards a gradual roll-out of Eudamed, the obligation to inform in...

    Read more

    Regulatory Affairs

    23 Feb 2024

    EU Council Endorses Proposal to Amend IVDR and MDR Regulations

    The Council of the European Union officially endorsed without any changes the proposal to amend...

    Read more

    Regulatory Affairs

    15 Nov 2024

    MDCG 2023-3 Rev 1 released

    On November 11th, 2024, the Medical Device Coordination Group (MDCG) released its first revision...

    Read more

    Regulatory Affairs

    5 Nov 2024

    New Q&A on the obligation to inform in case of interruption or discontinuation of supply

    On October 30th, 2024, the Medical Device Coordination Group (MDCG) released a Q&A on the...

    Read more

    Next

    • 1
    • 2
    • 3

    Discover all

    Stay ahead in life sciences

    Keeping up with the fast-paced life sciences industry doesn’t have to be overwhelming.

    Our newsletter delivers the latest insights, industry updates, and expert content directly to your inbox, helping you stay informed and make smarter decisions.

    Subscribe to our newsletter

    Circles-banner-short

    Twitter Widget Iframe